Product Name: Human IL-23P19 Antibody (Tildrakizumab, Research Use)
Catalog Number: NBR-0221
Target Name: IL-23P19
Trade Name: Tildrakizumab
Antibody Drug Description: Tildrakizumab, sold under the brand names Ilumya and Ilumetri, is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders.Tildrakizumab was designed to block interleukin-23 (IL-23), a cytokine that plays a key role in managing the immune system and autoimmune disease. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: IL-23P19
Synonyms: IL-23; IL-23A; IL23P19; P19; SGRF
Target Description: Associates with IL12B to form the pro-inflammatory cytokine IL-23 that plays different roles in innate and adaptive immunity.
Ensembl: ENSG00000110944 
Uniprot: Q9NPF7